Pharmacoeconomic benefit of cisplatin and etoposide chemoregimen for metastatic non small cell lung cancer: An Indian study

Pharmacoeconomic benefit of cisplatin and etoposide chemoregimen for metastatic non small cell lung cancer: An Indian study

Background: The incidence of lung cancer is rising in developing countries like India. Due to unaffordability among the low socioeconomic status (SES) patients, there is a significant delay in seeking appropriate medical treatment due to which a high proportion of patients present in an advanced/met...

Full description

Bibliographic Details
Main Authors: Mangesh P Kamath, K C Lakshmaiah, K Govind Babu, D Loknatha, Linu A Jacob, Suresh MC Babu
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2016-01-01
Series:Lung India
Subjects:
Cisplatin and etoposide
lower socioeconomic status
metastatic nonsmall lung cancer
pharmacoeconomics
Online Access:http://www.lungindia.com/article.asp?issn=0970-2113;year=2016;volume=33;issue=2;spage=154;epage=158;aulast=Kamath

Internet

http://www.lungindia.com/article.asp?issn=0970-2113;year=2016;volume=33;issue=2;spage=154;epage=158;aulast=Kamath

Similar Items